Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy

Clinical trial NCT02053064 · COMPLETED

Trial details

NCT number: NCT02053064
Sponsor: LYSOGENE
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mucopolysaccharidosis Type III A Sanfilippo Disease Type A

Start date: 2013-05-01
Primary completion: 2017-05-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.